FACIAL INJECTABLES MARKET ANALYSIS

Facial Injectables Market, By Product Type (Dermal Fillers (Hyaluronic Acid Fillers, Collagen Fillers and Synthetic Fillers) and Anti-wrinkle Injections (Botulinum Toxin A and Poly-L-lactic acid (PLLA)), By Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others), By End User (Hospitals, Beauty Clinics, and Dermatology Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI1329
Pages :182
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Facial injectables Market- Regional Insights

On the basis of region, the global facial injectables market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global facial injectables market over the forecast period. Increasing regulatory approvals of facial injectables have spurred the growth of the market. For instance, in December 2016, Galderma S.A received the U.S. Food and Drug Administration’s approval for two new products ‘Restylane and Refyne’ for the treatment of nasolabial folds (NLF) or laugh lines in patients aged 21. Refyne was approved for the treatment of facial wrinkles and folds, while Restylane Defyne was approved for the treatment of moderate to severe, deep facial wrinkles and folds.

Asia Pacific is expected to witness rapid growth in the global facial injectables market over the forecast period. The market in Asia Pacific is expected to gain momentum owing to new product launches. For instance, in 2017, Lsf Farma Ltd launched three products in the filler range to alter the dermal skin tissues in the India market.